Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04095442 · ClinicalTrials.gov registry record · NA
Effect of Antibacterial Mouthwash on Muscle Function in Healthy Young Men and Women
A NA study, sponsored by Indiana University.
- Completed
- Registry status
- NA
- Development phase
- 32
- Enrollment target
NCT04095442: Completed NA study, sponsored by Indiana University.
NCT04095442 is a NA study that has completed, run by Indiana University. The registered enrollment target is 32 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04095442, a NA study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effects of antibacterial mouthwash on muscle speed and power in healthy young men and women. We have previously demonstrated that drinking beetroot juice, a source of dietary nitrate and therefore nitric oxide, increases muscle function in this population. Antibacterial mouthwash has been shown to interfere with the conversion of dietary nitrate to nitric oxide. We therefore hypothesize that it will diminish nitric oxide bioavailability and inhibit muscle contractility.
Primary Outcome
Maximal knee extensor speed determined using isokinetic dynamometry
Interventions
- DEVICE Cepacol
- DEVICE Tom's Natural Mouthwash
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2019-11-01 |
| Est. Completion | 2023-03-20 |
| Phase | NA |
What the finished NCT04095442 record still lists
NCT04095442 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Cepacol is the first listed.
NCT04095442 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04095442 about?
NCT04095442 is a clinical study titled "Effect of Antibacterial Mouthwash on Muscle Function in Healthy Young Men and Women". The purpose of this study is to determine the effects of antibacterial mouthwash on muscle speed and power in healthy young men and women. We have previously demonstrated that drinking beetroot juice, a source of dietary nitrate and therefore nitric oxide, increases muscle function in this populatio...
What is the current status of trial NCT04095442?
This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2019-11-01. Estimated completion is 2023-03-20.
What interventions are being tested in trial NCT04095442?
The interventions under investigation include: Cepacol (DEVICE), Tom's Natural Mouthwash (DEVICE).
Who is sponsoring clinical trial NCT04095442?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04095442's enrollment target sits among peer trials
32 1578th of 2000 higher than 409 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI